Type
Internal restructuring
Country
France
Region
île de France; Yvelines;
Location of affected unit(s)
Chatou
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture Of Pharmaceutical Preparations

69 jobs
Number of planned job losses
Job loss
Announcement Date
5 February 2024
Employment effect (start)
15 March 2024
Foreseen end date
15 April 2024

Description

The management of Mayoly Spindler pharmaceutical laboratories in Chatou (Yvelines), has announced a reorganisation that will lead to cut up to 69 jobs on a total of 550 employees. Since December 2023, the company had been planning to reorganise its salesforce by bringing together 'two sales networks', which will have the impact of cutting 31 jobs and modifying 38 employment contracts (and lead to the same amount of job cuts if employees refuse the changes).

The company's social and economic committee, the Force Ouvrière pharmacy trade unions and the SEDIF-CFDT union (Energie-Chimie de l'Île-de-France CFDT) had applied to the interim relief judge of the Versailles administrative court to suspend the effects of this decision. However, the Versailles Administrative Court has approuved the implementation of the job protection plan (PSE), which was approved by the Île-de-France Regional and Interdepartmental Directorate for the Economy, Employment, Labour and Solidarity (DRIEETS). Therefore, then the company received a green light to implement the PSE.


Sources

Citation

Eurofound (2024), Laboratoires Mayoly Spindler, Internal restructuring in France, factsheet number 201021, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/201021.